PDB8 WILL IRBESARTAN LEAD TO COST SAVINGS DUE TO DELAYED...

PDB8 WILL IRBESARTAN LEAD TO COST SAVINGS DUE TO DELAYED END STAGE RENAL DISEASE IN HYPERTENSIVE TYPE-2 DIABETICS IN GERMANY?

O Pirk, KP Ratzmann, J Carels, P Bramlage, W Kirch
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Year:
2004
Language:
english
DOI:
10.1016/s1098-3015(10)65951-7
File:
PDF, 64 KB
english, 2004
Conversion to is in progress
Conversion to is failed